Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells

Systemic lupus erythematosus (SLE) is an autoimmune disease with a broad range of clinical manifestations and a heterogeneous disease course. There is no cure for SLE, but current standard pharmacotherapies can improve disease prognosis in most patients. However, some patients are refractory to conv...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cells Int
Autors principals: Wen, Lihui, Labopin, Myriam, Badoglio, Manuela, Wang, Dandan, Sun, Lingyun, Farge-Bancel, Dominique
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6525791/
https://ncbi.nlm.nih.gov/pubmed/31191681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7061408
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars